The Paediatric Rheumatology INternational Trials Organisation (PRINTO) is a not for profit, non governmental, international research network founded by Alberto Martini and Nicolino Ruperto in 1996. The coordinating centre is based in Genoa. PRINTO initially included 14 European countries (about 91 countries, 661 centres worldwide with 1429 members today), with the goal to foster, facilitate and co-ordinate the development, conduct, analysis, and reporting of multi-centres, international clinical trials and/or outcome standardisation studies in children with paediatric rheumatic diseases (PRD).
Via Gaslini, 5
Genova
Liguria
16147
Italy

Paediatric Rheumatology INternational Trials Organisation (PRINTO)

The Paediatric Rheumatology INternational Trials Organisation (PRINTO) is a not for profit, non governmental, international research network founded by Alberto Martini and Nicolino Ruperto in 1996. PRINTO initially included 14 European countries (about 91 countries, 661 centres worldwide with 1429 members today), with the goal to foster, facilitate and co-ordinate the development, conduct, analysis, and reporting of multi-centres, international clinical trials and/or outcome standardisation studies in children with paediatric rheumatic diseases (PRD).

The coordinating centre is based in Genoa.
To learn more about PRINTO click here
To download the PRINTO brochure click here


IN THE SPOTLIGHT

  • 23-OCT-2019
    PReS/PRINTO 2019 call for projects within the PReS WP2 OPEN!
    More details...
  • 15-MAR-2019
    EPOCA manuscript published in Lancet Child Adolesc Health!
    Paper details...
  • 04-FEB-2019
    First results of the PRINTO Consensus for new JIA Classification published!
    Paper details...
  • 27-DEC-2018
    Pharmacovigilance in JIA: Pharmachild manuscript published in ART!
    Paper details...
  • 16-AUG-2018
    Consensus proposal for Taxonomy of AIDs: manuscript published on ARD
    Paper details...
  • 24-MAY-2018
    Subcutaneous Abatacept in poly JIA Manuscript published in Arthritis & Rheu...
    More details...
  • 03-MAY-2018
    Genoa will host the 2019 Meeting of the International Society of Systemic A...
    More details...
  • 23-APR-2018
    Results of an international delphi survey for the definition of the variabl...
    Paper details...

PROJECTS

  • conect4children (c4c)
    PRINTO is partner of the "conect4children" (c4c) initiative, the collaborative network for European clinical trials for children, (c4c) a consortium that aims to enhance the competitiveness of Europe as a critical region for developing medicines for children.
    Learn More
  • Liaisons with pharmaceutical companies
    PRINTO is working with pharmaceutical companies as advisor for trials planning, centre selection, data collection, data analysis and interpretation…
    Learn More
  • The STARS Trial
    The comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS trial (STARS) is a new interventional trial aiming to investigate whether an early aggressive therapeutic intervention in children with JIA, based on the initial start of synthetic and biologic DMARDs (Step-down strategy), is superior to an approach based on treatment escalation conducted following the treat-to-target principle (Step-up strategy).
    Learn More
  • JIA classification study
    The PRINTO Evidence-based Revision of the International League Against Rheumatism (ILAR) Classification criteria for juvenile idiopathic Arthritis.
    Learn More
  • Eurofever
    The PReS Autoinflammatory Diseases’ Working Group, in collaboration with PRINTO, set up a a web-based international registry for Autoinflammatory diseases.
    Learn More
  • PharmaChild
    PRINTO and PRES are conducting a pharmacovigilance project which aims at observing children with JIA for 3-10 years undergoing treatment with MTX or biologic agents in order to collect moderate, severe or serious adverse events occurred.
    Learn More

CERTIFICATIONS

This website uses cookies. By continuing to browse the website you are agreeing to our use of cookies. Learn more   Accept cookies